Previous studies have shown that insulin resistance and subsequent hyperinsulinemia can enhance plasma circulating PCSK9 levels, and that the increase in plasma PCSK9 levels is related to poor glycemic control in patients with diabetes. This evidence concerns the gene PCSK9 and hyperinsulinism.